SEC Form 4 · accession 0001178913-18-000263
Foamix Pharmaceuticals Ltd. · FOMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Domzalski
Officer — CEO · Director
Period of report
Jan 1, 2018
Accepted (ET)
Jan 24, 2018 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606645
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jan 1, 2018 | M | 5,948 | $0.00 | A | 142,819 | D | |
| Ordinary SharesF3 | Jan 2, 2018 | F | 2,397 | $5.98 | D | 140,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F5,F4 | $0.00 | Jan 1, 2018 | M | 5,948 | D | — | — | Ordinary Shares | 5,948 | 0 | D |
Explanation of responses
- F1This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- F2The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 23,192 ordinary shares previously reported in Table I of the reporting person's Form 3, (ii) 5,948 ordinary shares underlying restricted share units that vested on January 1, 2018 and (ii) 113,679 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security.
- F3The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of restricted share units.
- F4The ordinary shares underlying this restricted share unit award vest over a period of four years (25% on January 1, 2018 and 6.25% every three months thereafter) ending January 1, 2021.
- F5This class of restricted share units is included in Column 5 of Table I above.